Incidental intracardiac thromboemboli during liver transplantation: Incidence, risk factors, and management
Open Access
- 31 August 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Liver Transplantation
- Vol. 16 (12), 1421-1427
- https://doi.org/10.1002/lt.22182
Abstract
Even though numerous cases of massive thromboemboli have been reported in the literature, intracardiac thromboemboli (ICTs) incidentally found during orthotopic liver transplantation (OLT) have not been examined. In this study, we retrospectively examined the incidence, risk factors, and management of incidental ICTs during OLT. After institutional review board approval, adult patients who underwent OLT between January 2004 and December 2008 at our center were reviewed. ICTs were identified and confirmed by the examination of OLT datasheets, anesthesia records, and recorded transesophageal echocardiography (TEE) clips. The clinical presentation, management, and outcomes of the patients with ICTs were reviewed. Risk factors were analyzed by multivariate logistic regression. During the study period, 426 of the 936 adult OLT patients (45.5%) underwent intraoperative TEE monitoring. Incidental ICTs were identified in 8 of these 426 patients (1.9%). Two ICTs occurred before reperfusion, and 6 ICTs occurred after reperfusion. The treatment was at the discretion of the treating physicians; however, none of the patients received an anticoagulant or thrombolytics. Multivariate analysis identified 2 independent risk factors for intraoperative incidental ICTs: the presence of symptomatic or surgically treated portal hypertension (a history of gastrointestinal bleeding, a transjugular intrahepatic portosystemic shunt procedure, or portocaval shunt surgery) before OLT and intraoperative hemodialysis (odds ratios of 4.05 and 7.29, respectively; P < 0.05 for both). In conclusion, incidental ICTs during OLT occurred at a rate of 1.9% and were associated with several preoperative and intraoperative risk factors. The use of TEE allows early identification, which may be important. Our management for incidental ICTs is described; however, no conclusions can be made about the optimal therapy. Liver Transpl 16:1421–1427, 2010. © 2010 AASLD.Keywords
This publication has 20 references indexed in Scilit:
- Intraoperative pulmonary embolism and intracardiac thrombosis complicating liver transplantation: a systematic reviewJournal of Thrombosis and Haemostasis, 2008
- Cardiovascular collapse due to massive pulmonary thromboembolism during orthotopic liver transplantationJournal of Clinical Anesthesia, 2006
- Successful Intraoperative Use of Recombinant Tissue Plasminogen Activator During Liver Transplantation Complicated by Massive Intracardiac/Pulmonary ThrombosisAnesthesia & Analgesia, 2006
- Four Cases of Cardiopulmonary Thromboembolism During Liver Transplantation Without the Use of Antifibrinolytic DrugsAnesthesia & Analgesia, 2005
- Review article: portal vein thrombosis – new insights into aetiology and managementAlimentary Pharmacology & Therapeutics, 2004
- Intravascular thrombosis and thromboembolism during liver transplantation: Antifibrinolytic therapy implicated?Liver Transplantation, 2004
- Antifibrinolytics in orthotopic liver transplantation: Current status and controversiesLiver Transplantation, 2004
- Intracardiac thrombus formation and pulmonary thromboembolism immediately after graft reperfusion in 7 patients undergoing liver transplantationLiver Transplantation, 2001
- Pulmonary Thromboembolism During Liver Transplantation: Possible Association with Antifibrinolytic Drugs and Novel Treatment OptionsAnesthesia & Analgesia, 2000
- TRANSESOPHAGEAL ECHOCARDIOGRAPHY REVEALS AN UNUSUAL CAUSE OF HEMODYNAMIC COLLAPSE DURING ORTHOTOPIC LIVER TRANSPLANTATION—TWO CASE REPORTSTransplantation, 1995